Ascendis Pharma A/S Stock Company Profile
Tuborg Boulevard 12
Hellerup 2900
45 70 22 22 44
ascendispharma.com
Industry: Biotechnology
Sector: Healthcare
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
